Clinical Trials
3 trialsNCT00923936 2018-07-24
Pilot Study of Liposomal Doxorubicin Combined With Bevacizumab Followed by Bevacizumab Monotherapy in Adults With Advanced Kaposi s Sarcoma
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00055237 2017-09-06
Bevacizumab to Treat Kaposi's Sarcoma in HIV-Positive and HIV-Negative Patients
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT01296815 2015-07-27
Intralesional Bevacizumab for Treating AIDS-associated Kaposi´s Sarcoma of the Larynx, Pharynx and Oral Cavity
Centro de Investigación en. Enfermedades Infecciosas, Mexico
Phase 2 Completed